Cargando…

Transforming Growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): A Matrix Protein with Dual Functions in Ovarian Cancer

Transforming growth factor-beta-induced protein (TGFBI, also known as βig-H3 and keratoepithelin) is an extracellular matrix protein that plays a role in a wide range of physiological and pathological conditions including diabetes, corneal dystrophy and tumorigenesis. Many reports indicate that βig-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ween, Miranda P., Oehler, Martin K., Ricciardelli, Carmela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431872/ https://www.ncbi.nlm.nih.gov/pubmed/22949874 http://dx.doi.org/10.3390/ijms130810461

Ejemplares similares

Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
por: Ween, Miranda P., et al.
Publicado: (2011)

The role of TGFBI (βig-H3) in gastrointestinal tract tumorigenesis
por: Han, Bing, et al.
Publicado: (2015)

Genotypic Homogeneity in Distinctive Transforming Growth Factor-Beta Induced (TGFBI) Protein Phenotypes
por: Han, Sang Beom, et al.
Publicado: (2021)

Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
por: Ricciardelli, Carmela, et al.
Publicado: (2013)

SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells
por: Tumbarello, David A., et al.
Publicado: (2016)

The Extracellular Matrix Protein TGFBI Induces Microtubule Stabilization and Sensitizes Ovarian Cancers to Paclitaxel
por: Ahmed, Ahmed Ashour, et al.
Publicado: (2007)

Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis
por: Lokman, Noor A., et al.
Publicado: (2013)

Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance
por: Ricciardelli, Carmela, et al.
Publicado: (2017)

Endothelial angiogenic activity and adipose angiogenesis is controlled by extracellular matrix protein TGFBI
por: Lee, Seul Gi, et al.
Publicado: (2021)

ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells
por: Tumbarello, David A, et al.
Publicado: (2012)

Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C
por: Steitz, Anna Mary, et al.
Publicado: (2020)

Control of cytokine-driven eosinophil migratory behavior by TGF-beta-induced protein (TGFBI) and periostin
por: Barretto, Karina T., et al.
Publicado: (2018)

Evidence against a blood derived origin for transforming growth factor beta induced protein in corneal disorders caused by mutations in the TGFBI gene
por: Karring, Henrik, et al.
Publicado: (2007)

Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein
Publicado: (1995)

Exploring the Immunoproteome for Ovarian Cancer Biomarker Discovery
por: Martin, Karina, et al.
Publicado: (2011)

Pharmaceutical modulation of the proteolytic profile of Transforming Growth Factor Beta induced protein (TGFBIp) offers a new avenue for treatment of TGFBI-corneal dystrophy
por: Venkatraman, Anandalakshmi, et al.
Publicado: (2020)

Comprehensively investigating the expression levels and the prognostic role of transforming growth factor beta-induced (TGFBI) in glioblastoma multiforme
por: Yin, Jun, et al.
Publicado: (2020)

TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
por: Wang, Ning, et al.
Publicado: (2012)

TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer
por: Lecker, Laura S.M., et al.
Publicado: (2021)

Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer
por: Pyragius, Carmen E., et al.
Publicado: (2013)

Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
por: Macpherson, Anne M., et al.
Publicado: (2020)

S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer
por: Noye, Tannith M., et al.
Publicado: (2018)

Investigation of TGFBI (Transforming growth factor beta-induced) Gene Mutations in Families with Granular Corneal Dystrophy Type 1 in the Konya Region
por: Malkondu, Fatma, et al.
Publicado: (2020)

A Comprehensive Molecular and Clinical Analysis of the piRNA Pathway Genes in Ovarian Cancer
por: Lee, Eunice, et al.
Publicado: (2020)

Chick Chorioallantoic Membrane (CAM) Assay as an In Vivo Model to Study the Effect of Newly Identified Molecules on Ovarian Cancer Invasion and Metastasis
por: Lokman, Noor A., et al.
Publicado: (2012)

Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer
por: Price, Zoe K., et al.
Publicado: (2023)

Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer
por: Arentz, Georgia, et al.
Publicado: (2023)

Identification of transforming growth factor beta induced (TGFBI) as an immune-related prognostic factor in clear cell renal cell carcinoma (ccRCC)
por: Du, Guo-Wei, et al.
Publicado: (2020)

Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer
por: Lokman, Noor A., et al.
Publicado: (2019)

Overexpression of piRNA Pathway Genes in Epithelial Ovarian Cancer
por: Lim, Shu Ly, et al.
Publicado: (2014)

ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome
por: Wang, Wanqi, et al.
Publicado: (2021)

Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2021)

4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2019)

TGFBI Protein Is Increased in the Urine of Patients with High-Grade Urothelial Carcinomas, and Promotes Cell Proliferation and Migration
por: Lang, Kerstin, et al.
Publicado: (2019)

Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis
por: Chiavarina, Barbara, et al.
Publicado: (2021)

Molecular genetics of Chinese families with TGFBI corneal dystrophies
por: Zhang, Ting, et al.
Publicado: (2011)

Evaluation of TGFBI corneal dystrophy and molecular diagnostic testing
por: Chao-Shern, Connie, et al.
Publicado: (2019)

A pathogenic variant in the transforming growth factor beta I (TGFBI) in four Iranian extended families segregating granular corneal dystrophy type II: A literature review
por: Mohammadi, Aliasgar, et al.
Publicado: (2020)

Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein
Publicado: (1994)

Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines
por: Khetan, Riya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n0sn6hb4scv0p3efk19bp9vjui